[Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
Satake
H
H
Second Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd.
Takechi
T
T
Nakano
K
K
Saito
H
H
Uchida
J
J
Takeda
S
S
Unemi
N
N
Fukushima
M
M
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004338:Drug Combinations; D005467:Floxuridine / Q000008:administration & dosage; D007940:Leukemia L5178 / Q000188:drug therapy* / Q000473:pathology*; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000556:secondary*; D008297:Male; D051379:Mice; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D004338:Drug Combinations; C096910:UFT(R) drug; D005467:Floxuridine; D005641:Tegafur; D014498:Uracil; C025034:doxifluridine